Executive Director, Global HEOR - Cell Therapy,

Executive Director, Global HEOR - Cell Therapy

Working with Us Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

A motivated, adaptable, inclusive, and decisive disposition is essential for success in this role. The Executive Director, Global HEOR - Cell Therapy must lead with a strong focus on building alignment, fostering collaborations, and enabling a high-performing, globally integrated team. The role requires deep expertise in health economics and outcomes research, coupled with a comprehensive understanding of global market access, and the ability to translate complex clinical, real-world, and economic evidence into clear, actionable strategies that inform senior leadership decision-making.

The Executive Director will lead the integrated evidence generation and value demonstration strategy across the Cell Therapy portfolio, ensuring tight alignment with market access, commercial, medical, and regulatory priorities. A key emphasis has been advancing enterprise-level real-world evidence capabilities, including linking registry data (e.g., CIBMTR) with claims and EHR datasets to generate differentiated insights on outcomes, durability, and healthcare resource utilization.

In close partnership with Global Market Access, Pricing, Policy, Medical Affairs and Commercial leadership, this role will shape both near- and long-term evidence strategies to address the evolving access landscape for cell therapies. The focus extends beyond traditional HEOR execution to tackling structural challenges such as site-of-care economics, provider adoption, and reimbursement pathways, while ensuring US and ex-US strategies are cohesive and forward-looking. The role also emphasizes talent development and team empowerment, enabling consistent delivery of high-quality evidence and strategic insights across the portfolio.

Responsibilities:

• Set and lead global HEOR and integrated evidence strategy across the lifecycle
• Advance innovative data and RWE capabilities
• Translate evidence into access, pricing, and value strategy and embed HEOR into cross-functional decision-making
• Develop evidence strategies supporting Cell Therapy class expansion and broader adoption
• Drive external engagement and scientific leadership, including thought leader partnerships
• Build, develop, and lead a high-performing global HEOR team
• Own portfolio prioritization, operations, and evidence gap closure

Qualifications:

• Advanced degree (PhD, PharmD, MPH, MS) in health economics, epidemiology, public health, or related field
• Minimum of 10 to 15 years' experience with a strong track record in HEOR, or real-world evidence generation in the pharmaceutical industry.
• Significant experience in HEOR, including study design and execution in real-world evidence (RWE), economic modeling, patient-reported outcomes (PROs), and HTA strategy
• Proven track record of leading integrated evidence strategies for complex or specialty therapeutic areas (Cell Therapy experience preferred)
• Strong understanding of global market access environments, including US payer and ex-US HTA requirements
• Demonstrated ability to translate complex data into clear, decision-ready insights for senior leadership and external stakeholders
• Experience influencing regulatory submissions, HTA engagements, and scientific publications/presentations
• Proven leadership in cross-functional collaboration across Market Access, Medical, Commercial, Regulatory, and Policy
• Experience advancing innovative data platforms (e.g., registry, claims, and EHR integration)
• Strong people leadership capabilities, with experience building and developing high-performing, inclusive teams
• Strategic mindset with the ability to balance near-term execution and long-term value demonstration priorities